TOETVA Technique Compared With Anterior Cervical Thyroidectomy (AC) in Terms of Efficacy and Safety

Recruiting N/A Interventional Study
Lobectomy Thyroidectomy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
616 (estimated)
Sponsor
University Hospital, Lille · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Nearly 50,000 thyroidectomies are performed in France each year for benign and malignant pathologies. Each one affects the life of the patient and represents, for some, suffering, symbolized by the stigma of the operation. The consequences of these scars vary according to the patient, their experience and their culture. For example, cervicotomies are particularly badly accepted in Asia since they …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with a surgical indication for lobectomy or thyroidectomy * Estimated thyroid volume measured by ultrasonography of less than 60 mL * Nodules suspected to be malignant measuring less than 4 cm * Patient aged between 18 and 65 years old * Patient who has benefited from…
Contacts

Robert Caiazzo, Prof.

+33 (0)3 20 44 55 15

robert.caiazzo@chu-lille.fr

CONTACT